AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo

AHN-GOOK PHARMACEUTICAL Co., Ltd.

Develops and markets medicines, focusing on respiratory and cardiovascular treatments.

001540 | KO

Overview

Corporate Details

ISIN(s):
KR7001540004
LEI:
Country:
South Korea
Address:
경기도 과천시 과천대로7길 12 (갈현동) 프리즘스퀘어2 A동, 과천시

Description

AHN-GOOK PHARMACEUTICAL Co., Ltd. is a pharmaceutical company that develops, manufactures, and markets a broad range of medicines. The company has a strong focus on treatments for the respiratory system and cardiovascular diseases. Its product portfolio includes prescription drugs, over-the-counter medications, and health supplements, with notable products such as Synatura Syrup for respiratory conditions, as well as treatments for digestive and ophthalmic health. The company is dedicated to promoting human health and improving quality of life through the development of innovative and effective pharmaceutical solutions for a global market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-08-14 00:00
[기재정정]분기보고서 (2020.03)
Korean 1.1 MB
2020-08-14 00:00
반기보고서 (2020.06)
Korean 1.2 MB
2020-06-29 00:00
신탁계약에의한취득상황보고서
Korean 16.4 KB
2020-06-26 00:00
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Korean 28.5 KB
2020-05-15 00:00
분기보고서 (2020.03)
Korean 1.1 MB
2020-03-30 00:00
사업보고서 (2019.12)
Korean 1.4 MB
2020-03-27 00:00
[기재정정]주요사항보고서(자기주식취득신탁계약체결결정)
Korean 28.7 KB
2020-03-25 00:00
주요사항보고서(자기주식취득신탁계약체결결정)
Korean 26.5 KB
2020-03-20 00:00
정기주주총회결과
Korean 18.7 KB
2020-03-12 00:00
감사보고서제출
Korean 27.5 KB
2020-03-05 00:00
주주총회소집공고
Korean 137.5 KB
2020-03-05 00:00
주주총회집중일개최사유신고
Korean 4.5 KB
2020-02-27 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.9 KB
2020-02-27 00:00
주주총회소집결의
Korean 7.4 KB
2020-02-25 00:00
현금ㆍ현물배당결정
Korean 9.1 KB

Automate Your Workflow. Get a real-time feed of all AHN-GOOK PHARMACEUTICAL Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AHN-GOOK PHARMACEUTICAL Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AHN-GOOK PHARMACEUTICAL Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alector, Inc. Logo
Clinical-stage biotech using immuno-neurology to treat neurodegenerative diseases.
United States of America
ALEC
ALK-Abelló Logo
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
Denmark
ALK
Alkaloid AD Logo
Manufactures generic pharmaceuticals, cosmetics, and chemical products.
North Macedonia
ALK
Alkermes plc. Logo
Develops and commercializes medicines for central nervous system (CNS) diseases.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
A clinical-stage biopharma using diagnostics to develop targeted cancer therapies.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Immunology company developing aluminum-free vaccines and therapies for allergies.
United Kingdom
AGY
Alligator Bioscience Logo
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Develops off-the-shelf allogeneic CAR T therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
Global biopharmaceutical company specializing in medical dermatology and skin health.
Spain
ALM
ALNYLAM PHARMACEUTICALS, INC. Logo
A biopharmaceutical company developing RNA interference (RNAi) therapeutics.
United States of America
ALNY

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.